2022

Agreement to boost and consolidate the Innovation and Health BioCluster project

The town councils of L’Hospitalet and Esplugues, the Bellvitge University Hospital, the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO), the Sant Joan de Déu Hospital and the University of Barcelona have signed an agreement to promote and consolidate the Innovation and Health BioCluster project.

Agreement to boost and consolidate the Innovation and Health BioCluster project Read More »

New mouse models boost personalized treatment research in endometrial cancer

To generate the new models a fresh biopsy of the original tumor was implanted into the same mouse tissue. This perfectly reproduces the original morphological and molecular characteristics, and therefore it anticipates the tumor evolution to choose the best treatment.

New mouse models boost personalized treatment research in endometrial cancer Read More »

The Prostate Cancer Group obtains a grant from USA Department of Defense federal funds

The Award from USA Department of Defense will fund a 3-year project to study the role of cancer cell chromatin on the landscape of prostate tumor immune microenvironment.

The Prostate Cancer Group obtains a grant from USA Department of Defense federal funds Read More »

The new reality in post-pandemic mental health is the focus of the ICS Research Conference hosted by IDIBELL

Mental health has been the focus of the debate addressed by the nearly 250 researchers from the seven research institutes of the Catalan Health Institute (ICS), who met this Monday, November 21, at the Bellvitge University Hospital (HUB) at the 13th ICS Research Conference.

The new reality in post-pandemic mental health is the focus of the ICS Research Conference hosted by IDIBELL Read More »

IDIBELL renews its animal welfare accreditation after the AAALAC visit

On November 10, the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) visited IDIBELL to supervise the correct execution of the program for the care and use of animals, essential for maintaining its accreditation. This certification ensures the institution’s commitment to animal welfare (in the models used in the research lines), maintaining

IDIBELL renews its animal welfare accreditation after the AAALAC visit Read More »

L’IDIBELL addresses in a NeuroDebat the current status of biomarkers of neurological pathologies

Motor neuron diseases, Alzheimer’s, headaches, and multiple sclerosis have been the four main blocks of NeuroDebat, organized by IDIBELL. The sessions were presented by Dr. Antoni Martínez Yélamos, group leader of IDIBELL and HUB, and moderated by professionals from the two centers and the Viladecans Hospital.

L’IDIBELL addresses in a NeuroDebat the current status of biomarkers of neurological pathologies Read More »

Scroll to Top